Home › Funds › BNY Mellon › MDGL
BNY Mellon position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)128.52K sh
Reported value held$69.01M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 44.70K | $3.57M | New |
| Q4 2021 | 34.74K | $2.94M | Reduce |
| Q1 2022 | 36.13K | $3.54M | Add |
| Q2 2022 | 36.49K | $2.61M | Add |
| Q3 2022 | 40.70K | $2.65M | Add |
| Q4 2022 | 42.97K | $12.47M | Add |
| Q1 2023 | 43.76K | $10.60M | Add |
| Q2 2023 | 56.50K | $13.05M | Add |
| Q3 2023 | 58.79K | $8.59M | Add |
| Q4 2023 | 62.18K | $14.39M | Add |
| Q1 2024 | 57.88K | $15.46M | Reduce |
| Q2 2024 | 73.81K | $20.68M | Add |
| Q3 2024 | 60.36K | $12.81M | Reduce |
| Q4 2024 | 60.21K | $18.58M | Hold |
| Q1 2025 | 60.79K | $20.14M | Add |
| Q2 2025 | 88.94K | $26.92M | Add |
| Q3 2025 | 97.78K | $44.85M | Add |
| Q4 2025 | 136.87K | $79.70M | Add |
| Q1 2026 | 135.91K | $71.14M | Reduce |
| Q2 2026 | 128.52K | $69.01M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MDGL
- Vanguard Group 1.81M sh · $1.05B · Q4 2025
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- BlackRock Inc 1.20M sh · $644.75M · Q2 2026
- Wellington Management Group 825.71K sh · $443.37M · Q2 2026
- Citadel Advisors 688.13K sh · $369.49M · Q2 2026
- UBS Group AG 401.71K sh · $215.70M · Q2 2026
- Geode Capital Management 374.88K sh · $201.34M · Q2 2026
- Fidelity Management & Research (FMR) 356.20K sh · $191.26M · Q2 2026
- Invesco Ltd 301.44K sh · $161.86M · Q2 2026
- Goldman Sachs Group 246.28K sh · $132.24M · Q2 2026
- Norges Bank Investment Management 213.89K sh · $114.85M · Q2 2026